{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:14:03Z","timestamp":1763036043128},"reference-count":71,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.idc.2005.03.005","type":"journal-article","created":{"date-parts":[[2005,6,20]],"date-time":"2005-06-20T16:04:24Z","timestamp":1119283464000},"page":"351-365","source":"Crossref","is-referenced-by-count":24,"title":["Fluoroquinolone-resistant Neisseria gonorrhoeae: the Inevitable Epidemic"],"prefix":"10.1016","volume":"19","author":[{"given":"Khalil G.","family":"Ghanem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie A.","family":"Giles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan M.","family":"Zenilman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2001","series-title":"Global prevalence and incidence of selected curable sexually transmitted infections overview and estimates","author":"World Health Organization","key":"10.1016\/j.idc.2005.03.005_bib1"},{"year":"2004","series-title":"Sexually transmitted disease surveillance, 2003","author":"Centers for Disease Control and Prevention","key":"10.1016\/j.idc.2005.03.005_bib2"},{"issue":"6","key":"10.1016\/j.idc.2005.03.005_bib3","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/jama.287.6.726","article-title":"Untreated gonococcal and chlamydial infection in a probability sample of adults","volume":"287","author":"Turner","year":"2002","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.idc.2005.03.005_bib4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9378(75)90477-9","article-title":"Effect of acute pelvic inflammatory disease on fertility","volume":"121","author":"Westrom","year":"1975","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.idc.2005.03.005_bib5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0002-9378(73)90635-2","article-title":"Tubal ectopic pregnancy: etiology and obstetric and gynecologic sequelae","volume":"117","author":"Franklin","year":"1973","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 4","key":"10.1016\/j.idc.2005.03.005_bib6","first-page":"308","article-title":"Pelvic inflammatory disease: etiology, diagnosis, and treatment","volume":"8","author":"Sweet","year":"1981","journal-title":"Sex Transm Dis"},{"issue":"1","key":"10.1016\/j.idc.2005.03.005_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/sti.75.1.3","article-title":"From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection","volume":"75","author":"Fleming","year":"1999","journal-title":"Sex Transm Infect"},{"issue":"4","key":"10.1016\/j.idc.2005.03.005_bib8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0197-0070(87)90006-4","article-title":"Diagnosing gonorrhea. A comparison of standard and rapid techniques","volume":"8","author":"D'Angelo","year":"1987","journal-title":"J Adolesc Health Care"},{"issue":"RR-15","key":"10.1016\/j.idc.2005.03.005_bib9","first-page":"1","article-title":"Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections\u20142002","volume":"51","author":"Johnson","year":"2002","journal-title":"MMWR Recomm Rep"},{"issue":"5","key":"10.1016\/j.idc.2005.03.005_bib10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/01.OLQ.0000124609.84050.F3","article-title":"Laboratory tests used in US public health laboratories for sexually transmitted diseases, 2000","volume":"31","author":"Dicker","year":"2004","journal-title":"Sex Transm Dis"},{"issue":"1","key":"10.1016\/j.idc.2005.03.005_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0272-2712(18)30287-7","article-title":"Multiplex polymerase chain reaction for the diagnosis of sexually transmitted diseases","volume":"16","author":"Mahony","year":"1996","journal-title":"Clin Lab Med"},{"issue":"11","key":"10.1016\/j.idc.2005.03.005_bib12","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/jama.264.11.1413","article-title":"National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project","volume":"264","author":"Schwarcz","year":"1990","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.idc.2005.03.005_bib13","first-page":"488","article-title":"Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2002","volume":"27","year":"2003","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.idc.2005.03.005_bib14","first-page":"34","article-title":"Penicillin resistance in gonorrhoea","volume":"36","author":"King","year":"1960","journal-title":"Br J Vener Dis"},{"issue":"37","key":"10.1016\/j.idc.2005.03.005_bib15","first-page":"563","article-title":"Tetracycline-resistant Neisseria gonorrhoeae\u2014Georgia, Pennsylvania, New Hampshire","volume":"34","year":"1985","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.idc.2005.03.005_bib16","first-page":"54","article-title":"Spectinomycin hydrochloride (Trobicin) in the treatment of gonorrhoea. Observation of resistant strains of Neisseria gonorrhoeae","volume":"49","author":"Reyn","year":"1973","journal-title":"Br J Vener Dis"},{"issue":"4","key":"10.1016\/j.idc.2005.03.005_bib17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00007435-199607000-00004","article-title":"A clinical isolate of Neisseria gonorrhoeae with in vitro resistance to erythromycin and decreased susceptibility to azithromycin","volume":"23","author":"Ehret","year":"1996","journal-title":"Sex Transm Dis"},{"issue":"4","key":"10.1016\/j.idc.2005.03.005_bib18","first-page":"251","article-title":"Relapse of gonorrhoea after treatment with penicillin or streptomycin","volume":"42","author":"Evans","year":"1966","journal-title":"Br J Vener Dis"},{"issue":"2","key":"10.1016\/j.idc.2005.03.005_bib19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00007435-197804000-00006","article-title":"A single large dose of trimethoprim-sulfamethoxazole fails to cure gonococcal urethritis in men","volume":"5","author":"Prior","year":"1978","journal-title":"Sex Transm Dis"},{"issue":"22","key":"10.1016\/j.idc.2005.03.005_bib20","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1001\/jama.1994.03510460025010","article-title":"Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones\u2014Ohio and Hawaii, 1992\u20131994","volume":"271","author":"From the Centers for Disease Control and Prevention","year":"1994","journal-title":"JAMA"},{"issue":"RR-6","key":"10.1016\/j.idc.2005.03.005_bib21","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines 2002","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Recomm Rep"},{"issue":"37","key":"10.1016\/j.idc.2005.03.005_bib22","first-page":"833","article-title":"Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999","volume":"49","year":"2000","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"46","key":"10.1016\/j.idc.2005.03.005_bib23","first-page":"1052","article-title":"Discontinuation of cefixime tablets\u2013United States","volume":"51","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"16","key":"10.1016\/j.idc.2005.03.005_bib24","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJM197704212961601","article-title":"Spectinomycin versus tetracycline for the treatment of gonorrhea","volume":"296","author":"Karney","year":"1977","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.idc.2005.03.005_bib25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1128\/.61.3.377-392.1997","article-title":"DNA gyrase, topoisomerase IV, and the 4-quinolones","volume":"61","author":"Drlica","year":"1997","journal-title":"Microbiol Mol Biol Rev"},{"issue":"4","key":"10.1016\/j.idc.2005.03.005_bib26","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1006\/jmbi.1996.0274","article-title":"DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage","volume":"258","author":"Chen","year":"1996","journal-title":"J Mol Biol"},{"issue":"35","key":"10.1016\/j.idc.2005.03.005_bib27","doi-asserted-by":"crossref","first-page":"22615","DOI":"10.1074\/jbc.273.35.22615","article-title":"The DNA gyrase-quinolone complex. ATP hydrolysis and the mechanism of DNA cleavage","volume":"273","author":"Kampranis","year":"1998","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.idc.2005.03.005_bib28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2958.1994.tb01297.x","article-title":"Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates","volume":"14","author":"Belland","year":"1994","journal-title":"Mol Microbiol"},{"issue":"2","key":"10.1016\/j.idc.2005.03.005_bib29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3201\/eid0702.010239","article-title":"Emerging mechanisms of fluoroquinolone resistance","volume":"7","author":"Hooper","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2005.03.005_bib30","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1073\/pnas.082092899","article-title":"Mechanism of plasmid-mediated quinolone resistance","volume":"99","author":"Tran","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.idc.2005.03.005_bib31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00007435-199705000-00002","article-title":"Fluoroquinolone treatment failure in gonorrhea. Emergence of a Neisseria gonorrhoeae strain with enhanced resistance to fluoroquinolones","volume":"24","author":"Deguchi","year":"1997","journal-title":"Sex Transm Dis"},{"issue":"6","key":"10.1016\/j.idc.2005.03.005_bib32","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0022-5347(01)63308-1","article-title":"Development of fluoroquinolone resistance and mutations involving GyrA and ParC proteins among Neisseria gonorrhoeae isolates in Japan","volume":"159","author":"Tanaka","year":"1998","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.idc.2005.03.005_bib33","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/jac\/40.3.458","article-title":"The effect of reserpine, an inhibitor of multi-drug efflux pumps, on the in-vitro susceptibilities of fluoroquinolone-resistant strains of Streptococcus pneumoniae to norfloxacin","volume":"40","author":"Brenwald","year":"1997","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.idc.2005.03.005_bib34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jac\/26.2.175","article-title":"Outer membrane proteins responsible for the penetration of beta-lactams and quinolones in Pseudomonas aeruginosa","volume":"26","author":"Yamano","year":"1990","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.idc.2005.03.005_bib35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/sti.74.1.59","article-title":"Analysis of quinolone resistance mechanisms in Neisseria gonorrhoeae isolates in vitro","volume":"74","author":"Tanaka","year":"1998","journal-title":"Sex Transm Infect"},{"issue":"11","key":"10.1016\/j.idc.2005.03.005_bib36","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1128\/AAC.44.11.3184-3185.2000","article-title":"Antimicrobial resistance of Neisseria gonorrhoeae and emerging ciprofloxacin resistance in the Netherlands, 1991 to 1998","volume":"44","author":"de Neeling","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.idc.2005.03.005_bib37","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1034\/j.1600-0463.2002.1100909.x","article-title":"Mutations in gyrA, gyrB, parC, and parE in quinolone-resistant strains of Neisseria gonorrhoeae","volume":"110","author":"Lindback","year":"2002","journal-title":"APMIS"},{"issue":"9","key":"10.1016\/j.idc.2005.03.005_bib38","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1128\/JCM.38.9.3489-3491.2000","article-title":"Characterization of Neisseria gonorrhoeae strains with decreased susceptibility to fluoroquinolones isolated in Greece from 1996 to 1999","volume":"38","author":"Mavroidi","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.idc.2005.03.005_bib39","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1128\/AAC.42.8.2103","article-title":"Identification of novel mutation patterns in the parC gene of ciprofloxacin-resistant isolates of Neisseria gonorrhoeae","volume":"42","author":"Trees","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idc.2005.03.005_bib40","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/AAC.47.1.436-439.2003","article-title":"Molecular characterization of quinolone-resistant Neisseria gonorrhoeae in Hong Kong","volume":"47","author":"Kam","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.idc.2005.03.005_bib41","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/01.OLQ.0000114654.91972.66","article-title":"Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 91 clinical isolates of Neisseria gonorrhoeae in Japan","volume":"31","author":"Shigemura","year":"2004","journal-title":"Sex Transm Dis"},{"issue":"11","key":"10.1016\/j.idc.2005.03.005_bib42","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1086\/386312","article-title":"Quinolone resistance-determining region mutations and por type of Neisseria gonorrhoeae isolates: resistance surveillance and typing by molecular methodologies","volume":"189","author":"Giles","year":"2004","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2005.03.005_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/AAC.45.1.117-123.2001","article-title":"Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998","volume":"45","author":"Su","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.idc.2005.03.005_bib44","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00007435-199810000-00009","article-title":"Analysis of quinolone resistance mechanisms in a sparfloxacin-resistant clinical isolate of Neisseria gonorrhoeae","volume":"25","author":"Tanaka","year":"1998","journal-title":"Sex Transm Dis"},{"issue":"6","key":"10.1016\/j.idc.2005.03.005_bib45","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00007435-200406000-00007","article-title":"High occurrence of simultaneous mutations in target enzymes and MtrRCDE efflux system in quinolone-resistant Neisseria gonorrhoeae","volume":"31","author":"Dewi","year":"2004","journal-title":"Sex Transm Dis"},{"issue":"11","key":"10.1016\/j.idc.2005.03.005_bib46","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1128\/AAC.39.11.2442","article-title":"Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin","volume":"39","author":"Knapp","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.idc.2005.03.005_bib47","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1086\/378809","article-title":"Gatifloxacin, gemifloxacin, and moxifloxacin: the role of 3 newer fluoroquinolones","volume":"37","author":"Saravolatz","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2005.03.005_bib48","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/jac\/48.4.545","article-title":"Frequency of selection of fluoroquinolone-resistant mutants of Neisseria gonorrhoeae exposed to gemifloxacin and four other quinolones","volume":"48","author":"Ruiz","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.idc.2005.03.005_bib49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0924-8579(03)00083-9","article-title":"In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyrA gene","volume":"22","author":"Ruiz","year":"2003","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.idc.2005.03.005_bib50","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jac\/39.2.247","article-title":"Antimicrobial activity of a new fluoroquinolone, DU-6859a, against quinolone-resistant clinical isolates of Neisseria gonorrhoeae with genetic alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV","volume":"39","author":"Deguchi","year":"1997","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.idc.2005.03.005_bib51","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.45.3.734-738.2001","article-title":"Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC","volume":"45","author":"Shultz","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"RR-14","key":"10.1016\/j.idc.2005.03.005_bib52","first-page":"1","article-title":"1993 sexually transmitted diseases treatment guidelines","volume":"42","author":"Centers for Disease Control and Prevention","year":"1993","journal-title":"MMWR Recomm Rep"},{"issue":"11","key":"10.1016\/j.idc.2005.03.005_bib53","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1128\/AAC.42.11.2919","article-title":"Drift in susceptibility of Neisseria gonorrhoeae to ciprofloxacin and emergence of therapeutic failure","volume":"42","author":"Ison","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2005.03.005_bib54","first-page":"90","article-title":"High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan","volume":"70","author":"Tanaka","year":"1994","journal-title":"Genitourin Med"},{"issue":"9","key":"10.1016\/j.idc.2005.03.005_bib55","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1128\/AAC.38.9.2200","article-title":"Emerging in vitro resistance to quinolones in penicillinase-producing Neisseria gonorrhoeae strains in Hawaii","volume":"38","author":"Knapp","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2005.03.005_bib56","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1086\/381546","article-title":"The epidemiology of fluoroquinolone-resistant Neisseria gonorrhoeae in Hawaii, 2001","volume":"38","author":"Newman","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"23","key":"10.1016\/j.idc.2005.03.005_bib57","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1001\/jama.288.23.2961","article-title":"Increases in fluoroquinolone-resistant Neisseria gonorrhoeae\u2014Hawaii and California, 2001","volume":"288","author":"From the Centers for Disease Control and Prevention","year":"2002","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.idc.2005.03.005_bib58","first-page":"335","article-title":"Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men\u2014United States, 2003, and revised recommendations for gonorrhea treatment, 2004","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.idc.2005.03.005_bib59","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1258\/0956462981922331","article-title":"Gonorrhoea treatment failure and ciprofloxacin resistance","volume":"9","author":"Ng","year":"1998","journal-title":"Int J STD AIDS"},{"issue":"5","key":"10.1016\/j.idc.2005.03.005_bib60","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1086\/517766","article-title":"Correlation between in vitro quinolone susceptibility of Neisseria gonorrhoeae and outcome of treatment of gonococcal urethritis with single-dose ofloxacin","volume":"28","author":"Kam","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2005.03.005_bib61","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1086\/319345","article-title":"Treatment failure with the use of ciprofloxacin for gonorrhea correlates with the prevalence of fluoroquinolone-resistant Neisseria gonorrhoeae strains in Bangladesh","volume":"32","author":"Rahman","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2005.03.005_bib62","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1086\/319998","article-title":"A randomized trial of ciprofloxacin versus cefixime for treatment of gonorrhea after rapid emergence of gonococcal ciprofloxacin resistance in The Philippines","volume":"32","author":"Aplasca De Los Reyes","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2005.03.005_bib63","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1128\/JCM.40.6.2037-2040.2002","article-title":"Antimicrobial susceptibility of Neisseria gonorrhoeae isolated in Bangladesh (1997 to 1999): rapid shift to fluoroquinolone resistance","volume":"40","author":"Rahman","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.idc.2005.03.005_bib64","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3201\/eid0301.970104","article-title":"Fluoroquinolone resistance in Neisseria gonorrhoeae","volume":"3","author":"Knapp","year":"1997","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2005.03.005_bib65","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/00007435-200212000-00008","article-title":"Characterization of ciprofloxacin resistance in Neisseria gonorrhoeae isolates in Canada","volume":"29","author":"Ng","year":"2002","journal-title":"Sex Transm Dis"},{"issue":"4","key":"10.1016\/j.idc.2005.03.005_bib66","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00007435-200204000-00010","article-title":"Surveillance of antibiotic resistance of Neisseria gonorrhoeae isolates in China, 1993\u20131998","volume":"29","author":"Ye","year":"2002","journal-title":"Sex Transm Dis"},{"issue":"8","key":"10.1016\/j.idc.2005.03.005_bib67","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1128\/AAC.48.8.3185-3187.2004","article-title":"Remarkable increase in central Japan in 2001\u20132002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones","volume":"48","author":"Ito","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.idc.2005.03.005_bib68","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1128\/AAC.46.6.1671-1673.2002","article-title":"High prevalence of high-level ciprofloxacin resistance in Neisseria gonorrhoeae in Tel Aviv, Israel: correlation with response to therapy","volume":"46","author":"Dan","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2005.03.005_bib69","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijantimicag.2004.04.003","article-title":"Ciprofloxacin resistant Neisseria gonorrhoeae in South Africa","volume":"24","author":"Moodley","year":"2004","journal-title":"Int J Antimicrob Agents"},{"issue":"1191","key":"10.1016\/j.idc.2005.03.005_bib70","first-page":"U817","article-title":"Antimicrobial susceptibility among Neisseria gonorrhoeae in New Zealand in 2002","volume":"117","author":"Heffernan","year":"2004","journal-title":"N Z Med J"},{"issue":"9372","key":"10.1016\/j.idc.2005.03.005_bib71","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/S0140-6736(03)13489-7","article-title":"Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002","volume":"361","author":"Fenton","year":"2003","journal-title":"Lancet"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552005000243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552005000243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T17:29:09Z","timestamp":1586280549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552005000243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0891552005000243"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2005.03.005","relation":{},"ISSN":["0891-5520"],"issn-type":[{"type":"print","value":"0891-5520"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}